Table 1 Clinical characteristics of AML... | American Society of Hematology

Table 1

Clinical characteristics of AML patients’ samples

Patient ID	Age, y	Sex	Subtype	Blasts in PB, %	Status	Cytogenetics
1	78	M	AML-M1	78	De novo	FLT3ITD⁺
2	58	F	AML-M4	89	Relapsed	FLT3ITD⁺
3	40	F	AML-M5	87	De novo	FLT3ITD⁺/NPM⁺
4	52	M	AML-M1	87	Refractory	Complex, multiple del./transloc., Bcr/Abl1⁺
5	43	F	AML-NOS	91	De novo	FLT3ITD⁺
6	74	F	AML-MLD (with prior MDS)	21	De novo	FLT3ITD⁺
7	51	M	AML-M4	71	Relapsed	Complex, multiple del./transloc.
8	65	M	AML-MLD (with prior MDS)	89	Relapsed	Normal
9	61	M	AML-M4	NR	De novo	Complex, multiple del./transloc.
10	58	F	AML-M4	60	De novo	Normal
11	74	M	AML-M5	51	Unknown	Complex, multiple del./transloc.
12	59	F	AML-M1	56	De novo	Normal
13	55	F	AML-NOS	93	Refractory	FLT3ITD⁺/NPM⁺
14	43	F	AML-MDS	50	Refractory	Complex, multiple del./transloc.

Patient ID	Age, y	Sex	Subtype	Blasts in PB, %	Status	Cytogenetics
1	78	M	AML-M1	78	De novo	FLT3ITD⁺
2	58	F	AML-M4	89	Relapsed	FLT3ITD⁺
3	40	F	AML-M5	87	De novo	FLT3ITD⁺/NPM⁺
4	52	M	AML-M1	87	Refractory	Complex, multiple del./transloc., Bcr/Abl1⁺
5	43	F	AML-NOS	91	De novo	FLT3ITD⁺
6	74	F	AML-MLD (with prior MDS)	21	De novo	FLT3ITD⁺
7	51	M	AML-M4	71	Relapsed	Complex, multiple del./transloc.
8	65	M	AML-MLD (with prior MDS)	89	Relapsed	Normal
9	61	M	AML-M4	NR	De novo	Complex, multiple del./transloc.
10	58	F	AML-M4	60	De novo	Normal
11	74	M	AML-M5	51	Unknown	Complex, multiple del./transloc.
12	59	F	AML-M1	56	De novo	Normal
13	55	F	AML-NOS	93	Refractory	FLT3ITD⁺/NPM⁺
14	43	F	AML-MDS	50	Refractory	Complex, multiple del./transloc.

del., deletion; F, female; ID, identification; ITD, internal tandem duplication; M, male; MDS, myelodysplastic syndrome; MLD, multilineage dysplasia; NOS, not otherwise specified; NPM, nucleophosmin; PB, peripheral blood; transloc., translocation.

View Large

This Feature Is Available To Subscribers Only